Ally Bridge Group as of June 30, 2024
Portfolio Holdings for Ally Bridge Group
Ally Bridge Group holds 25 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Soleno Therapeutics (SLNO) | 7.0 | $12M | 286k | 40.80 | |
| Sarepta Therapeutics (SRPT) | 6.9 | $12M | 74k | 158.00 | |
| Geron Corporation (GERN) | 6.9 | $12M | 2.7M | 4.24 | |
| Merus N V (MRUS) | 6.2 | $10M | 175k | 59.17 | |
| Insmed Com Par $.01 (INSM) | 5.1 | $8.6M | 129k | 67.00 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 5.1 | $8.6M | 195k | 44.29 | |
| Alumis (ALMS) | 4.9 | $8.2M | 619k | 13.30 | |
| Blueprint Medicines (BPMC) | 4.9 | $8.2M | 76k | 107.78 | |
| Disc Medicine (IRON) | 4.5 | $7.5M | 167k | 45.07 | |
| Day One Biopharmaceuticals I (DAWN) | 4.4 | $7.4M | 536k | 13.78 | |
| Mind Medicine Mindmed Com New (MNMD) | 4.1 | $7.0M | 965k | 7.21 | |
| Xenon Pharmaceuticals (XENE) | 3.9 | $6.6M | 169k | 38.99 | |
| Praxis Precision Medicines I Com New (PRAX) | 3.8 | $6.3M | 153k | 41.36 | |
| Kura Oncology (KURA) | 3.8 | $6.3M | 307k | 20.59 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 3.6 | $6.0M | 430k | 14.06 | |
| Longboard Pharmaceuticals In | 3.5 | $5.9M | 219k | 27.03 | |
| Cg Oncology (CGON) | 3.3 | $5.5M | 175k | 31.57 | |
| Jasper Therapeutics Com New (JSPR) | 3.0 | $5.0M | 219k | 22.70 | |
| Trevi Therapeutics (TRVI) | 2.6 | $4.4M | 1.5M | 2.98 | |
| Tyra Biosciences (TYRA) | 2.5 | $4.2M | 265k | 15.99 | |
| Perspective Therapeutics Com New (CATX) | 2.4 | $4.0M | 396k | 9.97 | |
| Black Diamond Therapeutics (BDTX) | 2.3 | $3.9M | 835k | 4.66 | |
| Context Therapeutics (CNTX) | 2.3 | $3.8M | 1.9M | 2.00 | |
| Eliem Therapeutics (CLYM) | 2.1 | $3.6M | 500k | 7.11 | |
| Promis Neurosciences Com New (PMN) | 0.9 | $1.6M | 1.1M | 1.50 |
